Oxford biodynamics signs supply and resale agreement with agilent technologies, and launches episwitch® explorer array kit for r&d use

Oxford, england--(business wire)--oxford biodynamics plc (aim: obd, the company), a biotechnology company developing precision medicine tests for personalized healthcare based on the episwitch® 3d genomics platform, and agilent technologies (nyse: a), a global leader in the life sciences, diagnostics, and applied chemical markets, have signed a supply and resale agreement for the manufacture and sale of the new episwitch® explorer array kit (“kit”). under the terms of the agreement, agilent wil
A Ratings Summary
A Quant Ranking